A Study to Find Out if Selexipag is Effective and Safe in Patients With Chronic Thromboembolic Pulmonary Hypertension When the Disease is Inoperable or Persistent/Recurrent After Surgery and/or Interventional Treatment
Clinical trial NCT03689244 · TERMINATED
Trial details
- NCT number
- NCT03689244
- Sponsor
- Actelion
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-23
- Primary completion
- 2022-06-07
- Enrollment
- 128
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.